Armistice Capital »

Sharkninja shares owned by Armistice Capital

Quarter-by-quarter ownership of Sharkninja (SN) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Sharkninja

Tip: Access up to 7 years of quarterly data

All positions including Sharkninja held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sharkninja by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $13M 214k 62.29
2023-09-30 $15M 327k 46.36

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Supernus Pharmaceuticals (SUPN)
Argenx Se Sponsored Adr (ARGX)
Deciphera Pharmaceuticals (DCPH)
Agios Pharmaceuticals (AGIO)
Immunovant (IMVT)
Sanofi Sponsored Adr (SNY)
Aurinia Pharmaceuticals (AUPH)
Dentsply Sirona (XRAY)
Travere Therapeutics (TVTX)

View all positions for Armistice Capital

Top funds holding Sharkninja

FMR
HighTower Advisors
Barrow, Hanley, Mewhinney & Strauss
Madison Avenue Partners
Alliancebernstein
Alua Capital Management
Millennium Management
Wolf Hill Capital Management
Thrivent Financial for Lutherans
Abrams Bison Investments
Morgan Stanley
Jericho Capital Asset Management
Pertento Partners
Newbrook Capital Advisors
Wellington Management Company

View all funds holding Sharkninja